Devonian Health Group Inc. (TSXV:GSD)
12.40
0.00 (0.00%)
At close: Mar 18, 2026
Devonian Health Group Revenue
Devonian Health Group had revenue of 1.05M CAD in the quarter ending October 31, 2025, a decrease of -82.81%. This brings the company's revenue in the last twelve months to 8.64M, down -63.96% year-over-year. In the fiscal year ending July 31, 2025, Devonian Health Group had annual revenue of 23.59M with 22.19% growth.
Revenue (ttm)
8.64M
Revenue Growth
-63.96%
P/S Ratio
1.85
Revenue / Employee
1.85M
Employees
11
Market Cap
34.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 23.59M | 4.28M | 22.19% |
| Jul 31, 2024 | 19.31M | 16.96M | 723.15% |
| Jul 31, 2023 | 2.35M | 40.20K | 1.74% |
| Jul 31, 2022 | 2.31M | 830.50K | 56.32% |
| Jul 31, 2021 | 1.47M | -668.47K | -31.19% |
| Jul 31, 2020 | 2.14M | -1.86M | -46.49% |
| Jul 31, 2019 | 4.00M | 837.05K | 26.42% |
| Jul 31, 2018 | 3.17M | - | - |
| Jul 31, 2017 | - | - | - |
| Jul 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDevonian Health Group News
- 4 weeks ago - Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects - PRNewsWire
- 4 weeks ago - Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls - PRNewsWire
- 5 weeks ago - Devonian reports additional molecular data from MASH liver study - PRNewsWire
- 5 weeks ago - DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY - PRNewsWire
- 6 weeks ago - DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT - PRNewsWire
- 2 months ago - DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING - PRNewsWire
- 3 months ago - Devonian Health Group Announces Grant of Stock Options - PRNewsWire
- 3 months ago - Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine™ as a Promising New Anti-Inflammatory Agent - PRNewsWire